All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Gene expression in actinic keratoses: pharmacological modulation by imiquimod

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F04%3A00000964" target="_blank" >RIV/00216208:11120/04:00000964 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Gene expression in actinic keratoses: pharmacological modulation by imiquimod

  • Original language description

    Background Actinic keratoses (AKs) are premalignant lesions that can progress into squamous cell carcinoma. Imiquimod, which belongs to the new class of immune-response modifiers, was recently shown to be effective in the treatment of AKs. The underlyingmechanisms are not fully understood. Objectives To study the expression of individual genes in uninvolved skin and AKs before therapy and to elucidate the way in which the expression of these genes is influenced by imiquimod therapy. Methods We treated13 patients with AK with imiquimod and compared gene expression before, during (five patients) and after (eight patients) therapy with that in uninvolved skin. We analysed genes coding for inflammatory cytokines or their receptors, adhesion molecules, anti-apoptotic proteins, p53 and toll-like receptors (TLRs) by reverse-transcriptase polymerase chain reaction. Results Comparing uninvolved skin and untreated AK, we found significant differences in the expression of interleukin (IL)-6, hu

  • Czech name

    Genová exprese u aktinických keratóz: farmakologická modulace imiquimodem

  • Czech description

    Aktinické keratózy jsou prekancerózy, které se mohou transformovat na spianliom. Imiquimod je určen k léčbě aktinických keratóz. Ve skupině 13 pacientů byla sledována genová exprese před, během a po terapii. Byly vyšetřovány geny, které kódují prozánětlivé cytokiny nebo jejich receptory, adhezivní molekuly, antiapoptotické proteiny, p53 a toll-like receptory s použitím RT-PCR. Bylo prokázáno, že lze najít specifické rozdíly v genové expresi mezi aktinickými keratózami a nepostiženou kůží

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FO - Dermatology and venereology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2004

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    British Journal of Dermatology

  • ISSN

    0007-0963

  • e-ISSN

  • Volume of the periodical

    151

  • Issue of the periodical within the volume

    6

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

  • UT code for WoS article

    000225628700005

  • EID of the result in the Scopus database